Aktie A1T9L2 EPIZYME, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Epizyme, Inc.

Aktien

A1T9L2

US29428V1044

EPZM

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Ipsen completes acquisition of Epizyme expanding its portfolio in oncology
France's Ipsen Finalizes Purchase of US Biopharmaceutical Group Epizyme
EPIZYME, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
Epizyme Announces Management Changes
Epizyme, Inc. Appoints Grant Bogle as Chief Executive Officer
Ipsen a finalisé le rachat de la société américaine Epizyme spécialisée en oncologie
Epizyme, Inc.(NasdaqGS:EPZM) dropped from NASDAQ Composite Index
Epizyme, Inc.(NasdaqGS:EPZM) dropped from S&P Global BMI Index
Epizyme, Inc.(NasdaqGS:EPZM) dropped from S&P TMI Index
Epizyme, Inc.(NasdaqGS:EPZM) dropped from NASDAQ Biotechnology Index
Ipsen Biopharmaceuticals, Inc. completed the acquisition of Epizyme, Inc. from RP Management LLC and others.
Epizyme : Reports Second Quarter 2022 Financial Results and Provides Business Update - Form 8-K
EPIZYME, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Epizyme: Q2 Earnings Snapshot
Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update
Earnings Flash (EPZM) EPIZYME Reports Q2 Revenue $27.5M
Epizyme, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Ipsen extends expiration date of tender offer for Epizyme, Inc. to 11 August 2022
Bolsa de Madrid: ¿Agosto siguiendo los pasos de julio?
Août sur la lancée de Juillet ?
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1T9L2 Aktie
  4. Nachrichten Epizyme, Inc.
  5. Andere Sprachen